AARON CLEVELAND: Open Payments
NPI 1497829147 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,219 in 46 payments from 7 companies in 2025. Trend: 2023 $12,551 · 2024 $15,511 · 2025 $16,219
Speaker / faculty: $11,530Travel & lodging: $3,552Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 38 | $16,029 |
| Novo Nordisk Inc | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| ViiV Healthcare Company | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $26 |
| Cipher Pharmaceuticals US LLC | 1 | $24 |
| QIAGEN, LLC | 1 | $23 |
Products named: Epclusa, Yeztugo, INVEGA SUSTENNA, Wegovy, APRETUDE, APTIMA, Natroba, Ozempic.
Industry payments across CA — which companies pay providers there.
